Dhiti Omics Technologies Private Limited - Due diligence report

A 360° intelligence report on Dhiti Omics: trust score, financial health, credit view, compliance, directors, growth and distress signals - …

2014-06-24 Banglore, Karnataka Active Unlisted Active Compliant
Share
DO Dhiti Omics Technologies Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Dhiti Omics — 360° Intelligence Report

Generated from MCA filings & public records
74/100
Trust Score
Moderate

Dhiti Omics is assessed as Moderate with a Trust Score of 74/100. Dhiti Omics is an active private limited indian non-government company incorporated in 2014, operating in the Life Sciences sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 20 Jul 2026 from the latest processed filings. Dhiti Omics Technologies Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
74/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
20/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.

Charges position: 1 open (26.94 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SUDHA NARAYAN RAO 01234567 Director 01/04/2018 6 yrs Approved
RAMESH KANNAN 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
17 allotment(s) · 1 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 70
Growth signals & trust indicators
Latest year revenue grew 38%.
Asset base grew 1.42 - capacity expansion.
Operating for 12+ years.
Active GST registration(s).
Distress signals & risk flags
Negative net worth.
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence83/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment49/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 26.94 Lakh already registered.
  • Compliance record supports lending.
Investor view52/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
22 Oct 2022
Securities allotted
3325 Preference Shares - 25.34 Lakh raised
03 Oct 2022
Securities allotted
3324 Preference Shares - 25.33 Lakh raised
30 Sep 2019
Director ceased
MEENA VAIDYANATHAN
31 Mar 2018
Securities allotted
820 Equity Shares - 8,200.00 raised
Securities allotted
325 Equity Shares - 3,250.00 raised
26 Sep 2016
Securities allotted
107 Equity Shares - 66,554.00 raised
31 Mar 2016
Share transfer (FY 2016)
5000.00000000 shares to Ramesh
30 Mar 2016
Securities allotted
4823 Equity Shares - 30.00 Lakh raised
Securities allotted
1608 Equity Shares - 10.00 Lakh raised
Securities allotted
4020 Equity Shares - 25.00 Lakh raised
Securities allotted
3215 Equity Shares - 20.00 Lakh raised
19 Nov 2015
Charge created
Hdfc Bank Limited - 26.94 Lakh
20 Jul 2015
Securities allotted
2000.00 Equity Shares - 20,000.00 raised
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a majority stake as per the FY 2022 annual return.
Capital has been raised through 17 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Sehat Skin And Hair Clinic Private Limited U85100TN2013PTC093667 Chennai, Tamil Nadu, India
Ayurveda Yogashram Remedies Private Limited U85190PB2013PTC037487 Amritsar, Punjab, India
Navicare U24110MH2011PTC216977 Mumbai, Maharashtra, India
Dha Tekhno Private Limited U74999GJ2017PTC096618 Ahmedabad, Gujarat, India
Urvaraa Ivf (Opc) Private Limited U74999WB2016OPC216526 Kolkata, West Bengal, India
Khushi Medicare Private Limited U85100DL2012PTC237667 New Delhi, Delhi, India
Hearing Instruments India Private Limited U74991AP2015PTC097522 Tirupathi, Andhra Pradesh, India
Riaan Diagnostic Private Limited U74110MH1998PTC117394 Nagpur, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Dhiti Omics before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Dhiti Omics: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 65/100, margin trends, ownership structure and peer set for Dhiti Omics - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 74/100, distress signals and MSME payment-delay disclosures - know whether Dhiti Omics pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Dhiti Omics - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Dhiti Omics an active company?

Dhiti Omics has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Dhiti Omics financially healthy?

Dhiti Omics has a Financial Health Score of 20/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Dhiti Omics?

Its overall Trust Score is 74/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Dhiti Omics?

Promoters hold a majority stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Dhiti Omics have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Dhiti Omics up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Dhiti Omics?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.